Skip to main content
  • Clinical Trials
Menu
Home
SPR
  • Healthcare Professionals
    • SPRINT® PNS System
      • Overview
      • Product Details
    • Clinical Evidence
    • Video Resources
    • Reimbursement
    • Education
    • Safety Information
    • MRI Safety Information
  • Patients & Caregivers
    • SPRINT® PNS System
      • Why SPRINT?
      • How It Works
      • What To Expect
      • Helpful FAQs
      • Safety Information
      • MRI Safety Information
    • Resources
      • Overview
      • Instructional Videos
      • Patient Stories
      • Recursos para pacientes
      • Clinical Evidence
  • About Us
    • About SPR
    • Leadership
    • Company Credo
  • News
  • Events
  • Careers
    • Overview
    • Job Listing
  • Contact Us

2025 NANS Annual Meeting

Breadcrumb

  1. Home
  2. 2025 NANS Annual Meeting

2025 NANS Annual Meeting

Thank you for joining SPR at NANS 2025. Below is a listing of the posters from this year's event. For more details, click on the individual titles below.

60-Day PNS vs. Standard Interventional Management for Chronic LBP: RESET RCT Primary Endpoint Results

Four-Year Follow-Up of Prospective, Multicenter Study of 60-day Peripheral Nerve Stimulation for Chronic Back Pain

Durable Improvements in Headache Pain After 60-Day PNS: Six-Month Outcomes of a Prospective Single-Arm Study

Percutaneous PNS Relieves Persistent Postoperative Pain and Improves Function: Long-term Follow-up from a Double-Blind RCT

Single-Center, Retrospective Chart Review of 60-Day Percutaneous Peripheral Nerve Stimulation Used to Treat Knee Pain

Bimodal 60-Day PNS Significantly Reduces Shoulder Pain: Outcomes From A Retrospective Multi-Center Chart Review

Shoulder Surgery Avoidance Through Multiple Years Following 60-Day PNS Treatment: Outcomes from a Cross-Sectional Follow-Up Survey Study

Long-Term Efficacy of 60-Day Peripheral Nerve Stimulation for Chronic Shoulder Pain: A Cross-Sectional Follow-Up Survey

Use of 60-day Percutaneous PNS for Sacroiliac (SI) Joint Pain: A Retrospective Review of Real-World Outcomes

Evaluating Consistency in Patient Reporting:​ Comparing Pain Relief Between EMRs and a Device Manufacturer Database

  • Healthcare Professionals
    • SPRINT® PNS System
      • Overview
      • Product Details
    • Clinical Evidence
    • Video Resources
    • Reimbursement
    • Education
    • Safety Information
    • MRI Safety Information
  • Patients & Caregivers
    • SPRINT® PNS System
      • Why SPRINT?
      • How It Works
      • What To Expect
      • Helpful FAQs
      • Safety Information
      • MRI Safety Information
    • Resources
      • Overview
      • Instructional Videos
      • Patient Stories
      • Recursos para pacientes
      • Clinical Evidence
  • About Us
    • About SPR
    • Leadership
    • Company Credo
  • News
  • Events
  • Careers
    • Overview
    • Job Listing
  • Contact Us
  • CPRA Requests
  • Consumer Health Data Request Form
  • Compliance
  • FCOI Policy
  • MRI Safety Information
  • Patent Information
  • Product Terms and Conditions
  • Safety Information
  • Trademarks
  • Billing Portal
Home
  • Consumer Health Data and Information Privacy Policy
  • Terms of Use
Visit us on Facebook
Visit us on Twitter
Visit us on Instagram
Visit us on YouTube
Visit us on LinkedIn

The SPRINT PNS System is indicated for up to 60 days for: (i) Symptomatic relief of chronic, intractable pain, post-surgical and post-traumatic acute pain; (ii) Symptomatic relief of post-traumatic pain; and (iii) Symptomatic relief of post-operative pain. The SPRINT PNS System is not intended to be placed in the region innervated by the cranial and facial nerves. Physicians should use their best judgment when deciding when to use the SPRINT PNS System. For more information see the SPRINT PNS System IFU. Most common adverse events are skin irritation and erythema. Results may vary. Rx only. 

View references for support of all claims.

Product and brand names/logos are registered or common law trademarks of SPR.

© 2025 SPR. All Rights Reserved.